Published in J Hyg (Lond) on April 01, 1981
An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) (1984) 3.38
The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) (1982) 2.09
The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02
Are many women immunized against rubella unnecessarily? J Hyg (Lond) (1981) 1.75
Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) (1983) 1.45
Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect (1988) 1.43
A micro-capture ELISA for detecting Mycoplasma pneumoniae IgM: comparison with indirect immunofluorescence and indirect ELISA. J Hyg (Lond) (1985) 1.32
Rubella-specific IgM detected by an antibody capture assay/ELISA technique. J Clin Pathol (1981) 1.27
Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM. J Hyg (Lond) (1983) 1.25
Use of monoclonal antibodies to human immunoglobulin M in "capture" assays for measles and rubella immunoglobulin M. J Clin Microbiol (1983) 1.22
Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against rubella virus. J Clin Microbiol (1994) 1.20
Specific IgG subclass antibody in rubella virus infections. Epidemiol Infect (1988) 1.20
Laboratory diagnosis of rubella: past, present and future. Epidemiol Infect (1991) 1.13
Evaluation of a commercial antibody capture enzyme immunoassay for the detection of rubella specific IgM. J Clin Pathol (1984) 0.96
Clinically apparent rubella reinfection with a detectable rubella specific IgM response. Br Med J (Clin Res Ed) (1983) 0.93
The detection of rubella-specific IgM by an immunosorbent assay with solid-phase attachment of red cells (SPARC). J Hyg (Lond) (1982) 0.92
Hemadsorption immunosorbent technique for determination of mumps immunoglobulin M antibody. J Clin Microbiol (1982) 0.91
The immunoglobulin M response to rubella vaccine in young adult women. J Hyg (Lond) (1984) 0.90
Clinical evaluation of the sensitivity and specificity of a commercially available enzyme immunoassay for detection of rubella virus-specific immunoglobulin M. J Clin Microbiol (1984) 0.87
Detection of specific immunoglobulin M antibody to rubella virus by use of an enzyme-labeled antigen. J Clin Microbiol (1985) 0.86
The avidity of specific IgM detected in primary rubella and reinfection. Epidemiol Infect (1990) 0.85
Development and evaluation of a capture enzyme-linked immunosorbent assay for determination of rubella immunoglobulin M using monoclonal antibodies. J Clin Microbiol (1987) 0.82
Screening for anti-rubella IgM ad libitum. J Hyg (Lond) (1983) 0.81
Fluoroimmunoassay for detection of rubella-specific immunoglobulin M: comparison with indirect enzyme immunoassay and mu-chain capture. J Clin Microbiol (1985) 0.81
Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG. J Clin Pathol (1991) 0.80
Development of a highly specific and sensitive rubella immunoglobulin M antibody capture enzyme immunoassay that uses enzyme-labeled antigen. J Clin Microbiol (1990) 0.78
Detection of immunoglobulins G and M to rubella virus by time-resolved immunofluorometry. J Clin Microbiol (1990) 0.77
Tests for detecting rubella specific IgM. J Clin Pathol (1985) 0.75
Public Health Laboratory Service IgM antibody capture enzyme linked immunosorbent assay for detecting rubella specific IgM. J Clin Pathol (1985) 0.75
Separation of hemagglutination-inhibiting immunoglobulin M antibody to rubella virus in human serum by high-performance liquid chromatography. J Clin Microbiol (1986) 0.75
Laboratory diagnosis and clinical significance of rubella in children with cancer. Epidemiol Infect (1989) 0.75
The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J (1973) 22.93
Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J (1968) 5.54
A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A. J Med Virol (1979) 4.40
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13
A solid-phase radioimmunoassay for detection of IgM antibodies to hepatitis A virus. J Infect Dis (1979) 3.15
The detection of specific IgM antibodies following infection with rubella virus. J Clin Pathol (1975) 2.49
Serum immunoglobulin levels in healthy children and adults. Clin Exp Immunol (1969) 2.15
Comparison of solid phase test systems for demonstrating antibodies against hepatitis A virus (anti-Hav) of the IgM-class. J Med Virol (1980) 1.68
Comparison of immunofluorescence and radioimmunoassay for detecting IgM antibody in infants with the congenital rubella syndrome. J Hyg (Lond) (1979) 1.57
[Virologic diagnosis of rubella. Findings in a rubella epidemic in a military training camp]. Schweiz Med Wochenschr (1980) 1.05
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Lancet (1984) 5.20
Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet (1985) 4.99
Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet (1983) 4.41
Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) (1983) 4.13
Rubella antibody measured by radial haemolysis. Characteristics and performance of a simple screening method for use in diagnostic laboratories. J Hyg (Lond) (1980) 4.13
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet (1990) 4.01
Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet (1987) 3.91
Human parvovirus arthropathy. Lancet (1985) 3.76
HIV surveillance by testing saliva. AIDS (1988) 3.43
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
A novel lymphotropic herpesvirus. Lancet (1987) 2.89
Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS (1997) 2.88
Failure to deliver hepatitis B vaccine: confessions from a genitourinary medicine clinic. BMJ (1991) 2.49
Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet (1987) 2.34
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Preliminary report: accurate assays for anti-HIV in urine. Lancet (1990) 2.17
Contrasting patterns and frequency of antibodies to the surface, core, and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol (1981) 2.16
The UK blood transfusion service: over a (patent) barrel? Lancet (2002) 2.15
Human herpesvirus 6 in salivary glands. Lancet (1990) 2.15
A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine. J Med Virol (1992) 2.15
Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. Genitourin Med (1986) 2.14
Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. J Med Virol (1993) 2.11
Prevalence of maternal HIV infection based on unlinked anonymous testing of newborn babies. Lancet (1990) 2.11
Birthing pools and infection control. Lancet (1996) 2.09
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (1993) 2.07
Febrile illness due to a parvovirus. Br Med J (1980) 2.05
The production of monoclonal antibodies to rubella haemagglutinin and their use in antibody-capture assays for rubella-specific IgM. J Hyg (Lond) (1982) 2.02
Which anti-HTLV III/LAV assays for screening and confirmatory testing? Lancet (1985) 1.94
New hepatitis B vaccines. Br Med J (Clin Res Ed) (1985) 1.93
Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7. BMJ (1989) 1.89
The 80th year of fifth disease. Br Med J (Clin Res Ed) (1984) 1.86
Diagnosis of hepatitis A and B by testing saliva. J Med Virol (1989) 1.82
Characterization of a virus that causes transient aplastic crisis. J Clin Invest (1984) 1.78
Human serum "parvovirus": a specific cause of aplastic crisis in children with hereditary spherocytosis. J Pediatr (1983) 1.77
Are many women immunized against rubella unnecessarily? J Hyg (Lond) (1981) 1.75
Cleavage of synthetic peptides by purified poliovirus 3C proteinase. J Biol Chem (1989) 1.72
Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation. J Gen Virol (1987) 1.71
Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet (1990) 1.69
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet (1995) 1.67
Immunohistochemical localization of galactosyltransferase in human fibroblasts and HeLa cells. J Histochem Cytochem (1981) 1.67
Age prevalence of antibody to human herpesvirus 6. Lancet (1988) 1.66
Comparison of radioimmunoassay and counter-immunoelectrophoresis for the detection of antibody to hepatitis B core antigen. J Virol Methods (1981) 1.65
Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet (1990) 1.64
Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods (2005) 1.57
Development of an enzyme-linked immunosorbent assay (ELISA) for hepatitis B e antigen and antibody. J Virol Methods (1981) 1.57
HBV DNA levels and transmission of hepatitis B by health care workers. J Clin Virol (2003) 1.54
Incidence of HIV infection in homosexual men in London, 1988-94. BMJ (1995) 1.52
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.51
Sero-immunity to poliovirus in children and young women: England 1972-4. J Hyg (Lond) (1975) 1.51
Prevalence of antibody to human T lymphotropic virus type III by risk group and area, United Kingdom 1978-84. Br Med J (Clin Res Ed) (1985) 1.50
Human parvovirus and the fetus. Lancet (1985) 1.50
Rational programme for screening travellers for antibodies to hepatitis A virus. Lancet (1988) 1.50
Hepatitis A in the traveller. Lancet (1983) 1.48
Adult T-cell leukaemia/lymphoma in Brazil and its relation to HTLV-I. Lancet (1990) 1.47
Rubella-specific IgM reactivity in sera from cases of infectious mononucleosis. J Hyg (Lond) (1983) 1.45
Prevalence of anti-HTLV-III in UK risk groups 1984/85. Lancet (1986) 1.45
Outbreak of hepatitis A in an extended family after importation by non-immune travellers. Epidemiol Infect (2011) 1.45
Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent. J Clin Pathol (1983) 1.41
Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS. J Med Virol (1994) 1.39
Economic donor screening for anti-HIV in the developing world. Vox Sang (1994) 1.39
Enhanced detection by PCR of hepatitis C virus RNA. Lancet (1990) 1.35
Edwardsiella tarda associated with human disease. Pathol Microbiol (Basel) (1971) 1.33
Detection of campylobacter species: a comparison of culture and polymerase chain reaction based methods. J Clin Pathol (2002) 1.33
Human parvovirus aplasia: case due to cross infection in a ward. Br Med J (Clin Res Ed) (1984) 1.33
Hepatitis C virus antibody. Lancet (1989) 1.33
Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br Med J (Clin Res Ed) (1987) 1.28
Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J Infect Dis (1995) 1.27
Detection by radioimmunoassay of IgM class antibody to hepatitis B core antigen: a comparison of two methods. J Med Virol (1980) 1.27
Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice. Vox Sang (2000) 1.27
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in London. Lancet (1984) 1.26
Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies. Hepatology (1986) 1.26
GACPAT HIV 1 + 2: a simple, inexpensive assay to screen for, and discriminate between, anti-HIV 1 and anti-HIV 2. J Med Virol (1995) 1.25
HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa. Lancet (1985) 1.25
Infection with human T cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London. BMJ (1990) 1.22
Diagnostic value of specific IgM antibodies in primary HIV infection. AIDS (1988) 1.21
Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies. J Hyg (Lond) (1983) 1.21
Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet (1984) 1.19
A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J Infect Dis (1996) 1.18
Hepatitis A virus infection among homosexual men. BMJ (1991) 1.18
HIV-2 antisera cross-neutralize HIV-1. AIDS (1988) 1.17
Characterization of the subclasses and light chain types of IgG antibodies to rubella. Clin Exp Immunol (1984) 1.16
Antibody assays for varicella-zoster virus: comparison of competitive enzyme-linked immunosorbent assay (ELISA), competitive radioimmunoassay (RIA), complement fixation, and indirect immunofluorescence assays. J Med Virol (1984) 1.16
Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology (1984) 1.16
HTLV-I/II antibodies in UK blood donors. Lancet (1990) 1.15
HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. BMJ (2000) 1.15